|
Patient-Provider Trust Among Individuals with End-Stage Kidney Disease Clinical Trials Info presented on Clinical Trials Search is not intended to be a substitute for certified medical advice, visits or professional assistance using a real physician. We are not physicians. Always consult your dr. about Patient-Provider Trust Among Individuals with End-Stage Kidney Disease conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Patient-Provider Trust Among Individuals with End-Stage Kidney Disease Clinical research trials and Patient-Provider Trust Among Individuals with End-Stage Kidney Disease health trials happen in many of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new drugs. The function of the studies / projects is to resolve particular human medical questions. Clinical trials are a popular manner for mDs, government agencies, and private sector corporations to discover remedies for all varieties of circumstances, like Patient-Provider Trust Among Individuals with End-Stage Kidney Disease. Patient-Provider Trust Among Individuals with End-Stage Kidney Disease Clinical Trials and other clinical trials allow volunteers to obtain healthcare treatment options before they are available to the masses. Some times the participants undergo professional assistance for free of charge, and occasionally they are paid for their time. Sometimes there is a cost for a Patient-Provider Trust Among Individuals with End-Stage Kidney Disease clinical trial. Human subjects often get the best healthcare available for their Patient-Provider Trust Among Individuals with End-Stage Kidney Disease condition. Dangers are a reality, however, and may include additional or frequent mD visits, healthcare dangers (potentially life-jeopardising), and/or the treatment being ineffectual. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Patient-Provider Trust Among Individuals with End-Stage Kidney Disease  Patient-Provider Trust Among Individuals with End-Stage Kidney Disease
Patient-Provider Trust Among Individuals with End-Stage Kidney Disease
For Condition: Kidney Failure, Chronic
Status: Recruiting
Sponsor(s): Warren G Magnuson Clinical Center (CC) ,
Synopsis: This study will examine communication and trust between patients in the kidney transplant process and their health care providers. It will assess patients' perception of trust in their physician and nurse coordinator; determine the patients' level of trust in the areas of competence, compassion, control, communication, and confidentiality; and determine how the trust level varies as patients progress in the transplant process. Patients 18 years of age and older who are in various stages of the kidney transplant process at Walter Reed Army Medical Center and the NIH Clinical Center may be eligible for this study. Candidates include individuals who: -are on dialysis but not on a transplant waiting list -are on the organ waiting list and are also on dialysis -are on the organ waiting list but are not on dialysis -have had a kidney transplant within the last year. Participants will be interviewed by someone who is not their direct health care provider about the doctor/patient, primary provider/patient, or nurse/patient relationship, their health history, medical condition, and ideas about their care. With the patient's permission, parts of the interview will be tape-recorded. The interview will take about 30 to 40 minutes.
Details: Health disparities related to the provision of, and access to, healthcare in the United States are well documented across racial and ethnic groups. One are of particular interest to health disparities researchers has been solid organ transplantation. Both provider and patient behaviors are implicated as contributing to ethnic variance of medical care in kidney transplantation. This pilot study will explore the perceptions of trust among patients in the kidney transplant process at the Warren Magnuson Clinical Center at the National Institutes of Health and at Walter Reed Army Medical Center. For sampling purposes the transplant process is defined as 1) patients currently on dialysis; 2) patients on the transplantation waiting list receiving dialysis; 3) patients on the transplantation waiting list not receiving dialysis; 4) patients newly transplanted (less than or equal to one year since transplantation) and 5) patients transplanted for greater than one year. Five dimensions contributing to trust have been identified in the literature: competence, compassion, control, communication and confidentiality. Face-to-face interviews to explore these five dimensions will include questions regarding demographic variables, the Trust in Physician Scale; the Trust in Nurse Scale, and the Patient Trust Scale. Results will be analyzed using descriptive statistics, Chi-square for categorical comparison of means and multivariate analysis for differences between groups.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: The investigators will interview a cohort of patients from Walter Reed Army Medical Center and the NIDDK intramural program in various stages of the transplant process. The stages are divided into the following categories: 1. individuals on dialysis but not on a waiting list 2. individuals on the organ waiting list who are also on dialysis 3. individuals on the organ waiting list but not on dialysis 4. individuals who have had a kidney transplant within the last year 5. individuals who have had a kidney transplant greater than one year EXCLUSION CRITERIA: 1. Patients less than 18 years old will not be included in this study. The interview questions and responses to the instruments may be inappropriate for children. 2. All other exclusions are as stated in the NIDDK and WRAMC parent protocols.
Total Enrollment: 325
Location and Contact Information:
Warren G. Magnuson Clinical Center (CC) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 040070; 04-CC-0070
Study Start Date: December 24, 2003
Record last reviewed: December 17, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00075036
Other Kidney Failure, Chronic Studies:
1. Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
2. Fifteen Year Follow-up of 5,500 Black and 5,500 Other Hypertensives
3. Isoflavones and Acute-phase Response in Chronic Renal Failure
4. Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis
5. Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant
Related Studies:
Other Kidney Failure, Chronic Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Patient-Provider Trust Among Individuals with End-Stage Kidney Disease
|
|
|
|
|
|
|
|
